INDV Stock Summary and Trading Ideas (Indivior Pharmaceuticals | NASDAQ:INDV)

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease.

Indivior Pharmaceuticals trades on the NASDAQ stock market under the symbol INDV.

As of February 23, 2026, INDV stock price declined to $32.93 with 1,111,324 million shares trading.

INDV has a beta of 0.56, meaning it tends to be less sensitive to market movements. INDV has a correlation of 0.04 to the broad based SPY ETF.

INDV has a market cap of $4.12 billion. This is considered a Mid Cap stock.

Last quarter Indivior Pharmaceuticals reported $314 million in Revenue and $.72 earnings per share. This beat revenue expectation by $53 million and exceeded earnings estimates by $.32.

The top ETF exchange traded funds that INDV belongs to (by Net Assets): IJR, IWM, VXF, SPSM, IJT.

INDV has outperformed the market in the last year with a return of +266.3%, while the SPY ETF gained +13.0%. However, in the most recent history, INDV shares have underperformed the stock market with its stock returning +3.7% in the last 3 month period and -4.2% for the last 2 week period, while SPY has returned +4.9% and -1.2%, respectively.

INDV support price is $33.15 and resistance is $34.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INDV shares will trade within this expected range on the day.